Abstract: An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.

Abstract: An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.

Abstract: The invention relates to a method for producing a medicament containing tadalafil. In said method, tadalafil is mixed with suitable adjuvants and is heated to a temperature of about 100° C. to about 200° C., preferably about 150° C. to about 200° C., especially about 200° C.

Abstract: The invention relates to a method for producing a medicament containing tadalafil. In said method, tadalafil is mixed with suitable adjuvants and is heated to a temperature of about 100° C. to about 200° C., preferably about 150° C. to about 200° C., especially about 200° C.

Abstract: An orally fast disintegrating dosage forms comprising functionalized natural or synthetic calcium carbonate, at least one active ingredient and at least one disintegrant, wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source, and wherein the tablet dissolves in less than 20 seconds when introduced into an aqueous environment.

Abstract: An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.

Abstract: The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropyl cellulose.

Abstract: The invention relates to a method for producing a medicament containing tadalafil. In said method, tadalafil is mixed with suitable adjuvants and is heated to a temperature of about 100° C. to about 200° C., preferably about 150° C. to about 200° C., especially about 200° C.

Abstract: The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropyl cellulose.

Abstract: Pharmaceutical compositions for oral administration comprising terbinafine and a method for administering high dosages while minimizing effects associated with e.g. a high dosage load, e.g. coated tablets or multiparticulate formulations such as minitablets or pellets, e.g. in capsules.

Abstract: Pharmaceutical compositions for oral administration comprising terbinafine and a method for administering high dosages while minimizing effects associated with e.g. a high dosage load, e.g. coated tablets or multiparticulate formulations such as minitablets or pellets, e.g. in capsules.

Abstract: The invention relates to a system for monitoring a layer (8), which is subjected to wear, of a composite structure (2) and relates especially to a system for monitoring the cover layer (8) of a conveyor belt (2). The monitoring system includes a transmitter/receiver device (4) which continuously generates an electromagnetic field. A ferromagnetic layer (16) of high permeability is embedded in the cover layer (8) and shields a transponder (6), which is embedded in the conveyor belt (2), from the electromagnetic field as long as it is not damaged by wear. The transmitter/receiver device (4) recognizes the wear of the cover layer (8) in that it receives data from the transponder (6) because, in this case, the ferromagnetic layer (16) is damaged over a large area. The invention also relates to a method for monitoring a composite structure (2) having a layer (8) subjected to wear. The invention relates especially to a method for monitoring the cover layer (8) of a conveyor belt (2).

Abstract: The invention relates to a method for monitoring a continuous revolving conveyor belt (4) having a connecting region (8). The connecting region (8) is monitored with the aid of two transponders (12) and (14). One of the transponders is arranged forward of the connecting region (8) and the other transponder is connected rearward of the connecting region (8). Both transponders (12) and (14) transmit respective signals to an external transmitter/receiver unit 16 wherein a conclusion is drawn as to the spacing of the two transponders (12) and (14) on the basis of the time-dependent spacing of the two signals. If the spacing s of the transponders (12) and (14) exceeds a pregiven amount, then a conclusion is drawn by the external transmitter/receiver unit (16) as to a critical change in length of the connecting region (8) and corresponding measures are initiated.

Abstract: A linear drive system has a guide rail and a transport device that is moveable along the guide rail. At least one tubular, flexible hollow body is positioned along the extension of the guide rail. The hollow body consists essentially of an elastomeric material and has a first and a second end. The at least one hollow body is loadable with a pressure medium from the first or the second end. At least one squeezing roller is rotatably connected to the transport device for forcing sealingly the at least one hollow body against a counter element. The guide rail consists essentially of a flexible elastomer.

Abstract: A tubular belt conveyor system includes a conveyor belt having a cross-sectionally closed, curvilinear, tubular configuration including a zone of overlapping edge portions. A plurality of support and guide assemblies for the conveyor are situated along the conveyor path. Each assembly includes a plurality of support and guide rollers held about the cross-sectionally closed conveyor belt in a contacting relationship therewith. In each assembly one roller is in engagement with the cross-sectionally closed conveyor belt at the edge overlap. The closed tubular configuration in each length portion of the conveying path has an oval cross section. The support and guide rollers force the conveyor belt into the closed tubular configuration of oval cross section. The first support and guide roller of each assembly is settable onto the zone of overlapping edge portions.

Abstract: A connection for two end portions of a conveyor belt or a power transmission belt of elastomeric material having a load-carrying member that is made of metal or woven material and is embedded between cover layers is provided. The free ends of the load-carrying member are placed together in a connection location that is covered by a reinforcement layer, which is embedded in elastomeric material, whereby in zones of the free ends of the load-carrying member, the reinforcement layer is interrupted.